PER 0.00% 8.0¢ percheron therapeutics limited

Ann: Appendix 4E and Full Year Statutory Accounts, page-48

  1. 3,227 Posts.
    lightbulb Created with Sketch. 259
    The largest number of DMD cases in Europe are in U.K. followed by Germany.
    U.K. if am not wrong has already approved trial so asa Germany approves it it would make a lot of sense, even economically, to start trial without seeking any other countries. Don’t know if reducing the number of countries the money in the bank will get us to futility but for sure everyone would feel more comfortable, market included maybe.
    P.S. I wonder if this scenario has crossed Koutchin the great adviser mind and as a consequence the Diamond’s future action.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.63K 158.7K

Buyers (Bids)

No. Vol. Price($)
2 66500 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 273231 2
View Market Depth
Last trade - 15.26pm 19/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.